Attributes | Values |
---|
rdf:type
| |
Description
| - Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces the rate of cardiovascular events among patients with left-ventricular dysfunction and those at high risk of such events. We assessed whether the ACE inhibitor perindopril reduced cardiovascular risk in a low-risk population with stable coronary heart disease and no apparent heart failure.
- Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces the rate of cardiovascular events among patients with left-ventricular dysfunction and those at high risk of such events. We assessed whether the ACE inhibitor perindopril reduced cardiovascular risk in a low-risk population with stable coronary heart disease and no apparent heart failure. (en)
- Léčba ACE inhibitory snižuje výskyt kardiobvaskulárních příhod u pacientů s dysfunkcí levé komory a nemocných s vysokým rizikem těchto příhod. My jsme posuzovali, zda inhibitor ACE-perindopril snižuje kardiovaskulární riziko u populace s stabilní ischemickou chorobou srdeční, bez srdečního selhání a s nízkým stupněm rizika. (cs)
|
Title
| - Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary atery disease: randomized, double-blind, placebo-controlled, multicentre trial
- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary atery disease: randomized, double-blind, placebo-controlled, multicentre trial (en)
- Účinnost perindoprelu při poklesu kardiovaskulárních příhod u pacientů se stabilní ischemickou chorobou srdeční: randomizovaná, dvojitě slepá, placebem konntrolovaná, multicentrická stuide (cs)
|
skos:prefLabel
| - Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary atery disease: randomized, double-blind, placebo-controlled, multicentre trial
- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary atery disease: randomized, double-blind, placebo-controlled, multicentre trial (en)
- Účinnost perindoprelu při poklesu kardiovaskulárních příhod u pacientů se stabilní ischemickou chorobou srdeční: randomizovaná, dvojitě slepá, placebem konntrolovaná, multicentrická stuide (cs)
|
skos:notation
| - RIV/00216208:11120/03:00001016!RIV09-MSM-11120___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216208:11120/03:00001016
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Converting-enzyme-inhibitor; left-ventricular dysfunction; myocardial-infarction; blood-pressure; heart-failure; ejection fractions; enlargement trial; endothelial-cells; hypertension; mortality (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Widimský, Petr
- Fox, K. M.
- Ferrari, R.
- Bertrand, M.
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |